As shown in Figure 2B, 2C, higher expression of AURKB contributed to significantly worse overall survival (OS, p=0.002) and progression-free survival (PFS, p=0.013), indicating that AURKB is associated with poor prognosis in patients with lung adenocarcinoma. The gene discussed is AURKB; the disease is lung adenocarcinoma.